Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience

BACKGROUND: No study has evaluated the direct annual costs of inflammatory bowel disease patients treated with anti-tumour necrosis factor therapy. OBJECTIVES: The purpose of this study was to identify annual direct costs and main cost drivers of anti-tumour necrosis factor-treated inflammatory bowe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:United European Gastroenterol J
Asıl Yazarlar: Lawton, Jean, Achit, Hamza, Pouillon, Lieven, Boschetti, Emmanuelle, Demore, Béatrice, Matton, Thierry, Tournier, Charlène, Prodel, Martin, Peyrin-Biroulet, Laurent, Guillemin, Francis
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6683635/
https://ncbi.nlm.nih.gov/pubmed/31428415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619853448
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller